Patents by Inventor Midori Nakamura

Midori Nakamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ink set and ink jet recording method
    Patent number: 11952501
    Abstract: An ink set of radiation curable ink jet compositions, includes: an under layer ink; and an over layer ink, and the under layer ink contains, as a polymerizable compound, 80.0 percent by mass or more of a monofunctional polymerizable compound with respect to a total mass of polymerizable compounds and contains 55.0 percent by mass or more of a polymerizable compound having a nitrogen heterocyclic structure and/or a polymerizable compound having a hydroxy group in total with respect to the total mass of the polymerizable compounds.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: April 9, 2024
    Assignee: SEIKO EPSON CORPORATION
    Inventors: Midori Sekine, Kyohei Tanaka, Kiyoshi Nakamura
  • Body Supporting Device and Fan Unit Bag
    Publication number: 20230137642
    Abstract: A baby carriage equipped with a backrest part is further provided with a fan unit bag that is mounted at the rear of the backrest part The fan unit bag comprises: a fan unit which draws in air from the backrest part a fan base which is made of a low air-permeability sheet and which supports the fan unit such that the fan unit faces the backrest part; and a fixation part which is disposed so as to surround the fan unit and which detachably mounts the fan base to the backrest part.
    Type: Application
    Filed: June 16, 2021
    Publication date: May 4, 2023
    Inventors: Nobuyoshi Miyasaka, Midori Nakamura
  • Therapeutic Agent for Osteoporosis Using a Retinoid X Receptor-Related Compound
    Publication number: 20090270612
    Abstract: It is an object of the present invention to provide a novel therapeutic agent for osteoporosis. HX531 is utilized, which is synthesized as a retinoid X receptor antagonist and has an activity in inhibiting a differentiation into adipocytes. Furthermore, any dosage form containing HX531 as an effective component can be used.
    Type: Application
    Filed: September 4, 2006
    Publication date: October 29, 2009
    Inventors: Nobuyuki Udagawa, Midori Nakamura, Hiroyuki Kagechika